Further experiments involving reintroducing the CPGL gene, or its splicing variant CPGL-B, into CPGL-deficient pancreatic cancer cells showed a reduction in anchorage-independent cell growth and migration while promoting G1 accumulation. This evidence concerns the gene CNDP2 and pancreatic neoplasm.